4//SEC Filing
CHANG LINDA L 4
Accession 0001123292-18-000423
CIK 0001360886other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 10:34 AM ET
Size
5.3 KB
Accession
0001123292-18-000423
Insider Transaction Report
Form 4
CHANG LINDA L
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2018-02-26$8.92/sh+20,000$178,400→ 20,000 totalExercise: $8.92From: 2019-02-26Exp: 2028-02-25→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]5,000 shares underlying this option shall vest on each of February 26, 2019, February 26, 2020, February 26, 2021 and February 26, 2022, subject to Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001535179
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 10:34 AM ET
- Size
- 5.3 KB